Gewählte Publikation:
Gilsbach, JM; Reulen, HJ; Ljunggren, B; Brandt, L; von Holst, H; Mokry, M; von Essen, C; Conzen, MA.
Early aneurysm surgery and preventive therapy with intravenously administered nimodipine: a multicenter, double-blind, dose-comparison study.
Neurosurgery. 1990; 26(3): 458-464.
Doi: 10.1227/00006123-199003000-00013
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
-
Mokry Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- A European, multicenter, prospective, randomized, double-blind, dose-comparison study on preventive therapy with intravenously administered nimodipine was performed to evaluate the efficacy and tolerability of two different doses: 2 and 3 mg/h. Two hundred four patients fulfilled the criteria for enrollment in the study: surgery within 72 hours after the last subarachnoid hemorrhage, and age between 16 and 72 years. All patients who had Hunt and Hess grades of I to III were operated upon; patients who had poor Hunt and Hess grades (IV-V) were operated on according to the surgeon's choice. This treatment regimen was associated with a low incidence of delayed neurological dysfunction with no significant difference between the two dosage groups: three patients (1.5%) remained severely disabled and two (1%) moderately disabled due to vasospasm with or without additional complications. Among the patients with Hunt and Hess grades of IV or V, the long-term outcome was favorable (good-fair) for 40% and unfavorable for 60%. Among the patients with grades of I to III, the long-term outcome was favorable for 89% and unfavorable for 11%.
- Find related publications in this database (using NLM MeSH Indexing)
-
Dose-Response Relationship, Drug -
-
Double-Blind Method -
-
Female -
-
Humans -
-
Injections, Intravenous -
-
Intracranial Aneurysm - drug therapy
-
Male - drug therapy
-
Middle Aged - drug therapy
-
Multicenter Studies - drug therapy
-
Nimodipine - administration and dosage